Study Reveals Genetic Features of Rhabdomyosarcoma That May Improve Risk Stratification
Integrating molecular profiling into current clinical stratification could improve outcomes in rhabdomyosarcoma, according to researchers.
Latest Features
LATEST ARTICLES
Blood-Based Test May Establish a ‘New Paradigm’ for Cancer Screening
The test can accurately detect cancer and predict where it is located, according to researchers.
KRAS G12C Mutations in Metastatic Colorectal Cancer: Questions Remain
Dr Alan Lyss reviews studies of KRAS G12C mutations in metastatic colorectal cancer.
Racial/Ethnic Minorities Have Higher Risk of Familial-Associated Early-Onset Cancer
The study showed differences by cancer type and race/ethnicity.
Experts Review the State of Colorectal Cancer Screening in the COVID-19 Era
Two experts discuss the future of colorectal cancer screening and lessons learned during the era of COVID-19.
How to Prevent COVID-19 Vaccination From Interfering With Cancer Imaging
Education, communication, and coordination are key.
Overcoming Obstacles to Health Equity in Breast Cancer Prevention and Control
The current scientific evidence may not be generalizable to underrepresented groups.
Platinum Chemotherapy Appears to Cause Clonal Expansion Leading to Myeloid Neoplasms in Children With Neuroblastoma
Children treated for neuroblastoma developed myeloid neoplasms with specific platinum chemotherapy-associated mutation signatures.
On-Treatment Ki-67: A Promising Prognostic Marker for Early Breast Cancer Management
Dr Alan Lyss reviews results from the high-risk cohort of the WSG-ADAPT HR+/HER2- trial.
Osimertinib Combinations as Second-Line Treatment in Non-Small Cell Lung Cancer: The Jury’s Still Out
Results from the BOOSTER trial add to data suggesting no benefit with osimertinib in combination over osimertinib alone.
ASCO and Friends: Cancer Patients Should Be Included in COVID-19 Vaccine Trials
A statement recommends including cancer patients and survivors in COVID-19 vaccine trials.
Melanoma Brain Metastases: ‘Absolutely Treatable in 2021’
Experts outline treatment options and make recommendations.
Closing the Gap Between Cancer Patients and Researchers: A Patient Advocate’s Perspective on GRASP
Patient advocate Marlena Murphy provides a patient’s perspective on GRASP.
The Past, Present, and Future of GRASP: Connecting Cancer Researchers, Clinicians, and Patient Advocates
GRASP co-founder Julia Maués explains how the initiative came about and reveals plans for the future.
Epigenetic Clock May Reveal Biological Aging After Cancer Treatment and Allow for Objective Measurement of Fatigue
Researchers found associations between epigenetic age acceleration, inflammation, and fatigue in cancer patients.
- Loading...
Loading...
Want to read more?
Please login or register first to view this content.
Loading... 
Loading...